May 6th 2025
The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung cancer (SCLC), but it was also linked to higher rates of serious adverse events like cytokine release syndrome than seen in clinical trials.
Will The Affordable Care Act Ever Achieve Its Lofty Goal?
July 9th 2012On June 28, 2012, the United States Supreme Court upheld the 2010 Patient Protection and Affordable Care Act (PPACA), setting into motion changes that will transform the way in which healthcare services are reimbursed and delivered. The result of this decision has sparked widespread debate on whether the PPACA will accomplish what it was intended to.
Read More